Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension

Background— Excessive diastolic left ventricular stiffness is an important contributor to heart failure in patients with diabetes mellitus. Diabetes is presumed to increase stiffness through myocardial deposition of collagen and advanced glycation end products (AGEs). Cardiomyocyte resting tension also elevates stiffness, especially in heart failure with normal left ventricular ejection fraction (LVEF). The contribution to diastolic stiffness of fibrosis, AGEs, and cardiomyocyte resting tension was assessed in diabetic heart failure patients with normal or reduced LVEF. Methods and Results— Left ventricular endomyocardial biopsy samples were procured in 28 patients with normal LVEF and 36 patients with reduced LVEF, all without coronary artery disease. Sixteen patients with normal LVEF and 10 with reduced LVEF had diabetes mellitus. Biopsy samples were used for quantification of collagen and AGEs and for isolation of cardiomyocytes to measure resting tension. Diabetic heart failure patients had higher diastolic left ventricular stiffness irrespective of LVEF. Diabetes mellitus increased the myocardial collagen volume fraction only in patients with reduced LVEF (from 14.6±1.0% to 22.4±2.2%, P<0.001) and increased cardiomyocyte resting tension only in patients with normal LVEF (from 5.1±0.7 to 8.5±0.9 kN/m2, P=0.006). Diabetes increased myocardial AGE deposition in patients with reduced LVEF (from 8.8±2.5 to 24.1±3.8 score/mm2; P=0.005) and less so in patients with normal LVEF (from 8.2±2.5 to 15.7±2.7 score/mm2, P=NS). Conclusions— Mechanisms responsible for the increased diastolic stiffness of the diabetic heart differ in heart failure with reduced and normal LVEF: Fibrosis and AGEs are more important when LVEF is reduced, whereas cardiomyocyte resting tension is more important when LVEF is normal.

[1]  J. Bronzwaer,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.

[2]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[3]  Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction , 2003 .

[4]  S. Factor,et al.  A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. , 1990, Circulation.

[5]  Jeroen J. Bax,et al.  Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. , 2003, Journal of the American College of Cardiology.

[6]  J. Bronzwaer,et al.  Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy. , 2003, American journal of physiology. Heart and circulatory physiology.

[7]  A. Reddi,et al.  Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart. , 1996, Circulation.

[8]  W. Paulus,et al.  Different effects of two types of ischemia on myocardial systolic and diastolic function. , 1985, The American journal of physiology.

[9]  G. Lamas,et al.  Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. , 2004, Archives of internal medicine.

[10]  C. Stehouwer,et al.  Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. , 2004, Biochimica et biophysica acta.

[11]  H. Taegtmeyer,et al.  Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms , 2002, Circulation.

[12]  Merlin C. Thomas,et al.  A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes , 2003, Circulation research.

[13]  D. Kass,et al.  Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.

[14]  B. Howard,et al.  Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. , 2002, Diabetes.

[15]  Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart. , 2002 .

[16]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[17]  H. Taegtmeyer,et al.  Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. , 2002, Circulation.

[18]  D. Levy,et al.  Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study , 2003, Circulation.

[19]  J. Crowley,et al.  The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.

[20]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[21]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[22]  D. Kass,et al.  What Mechanisms Underlie Diastolic Dysfunction in Heart Failure? , 2004, Circulation research.

[23]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .

[24]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[25]  M. Kamalesh,et al.  Disproportionate increase in prevalence of diabetes among patients with congestive heart failure due to systolic dysfunction. , 2005, International journal of cardiology.

[26]  W. Hundley,et al.  Heart failure prevalence, incidence, and mortality in the elderly with diabetes. , 2004, Diabetes care.

[27]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[28]  J. Bronzwaer,et al.  Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. , 1999, Circulation.

[29]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[30]  D. Kass,et al.  Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. , 2007, Journal of the American College of Cardiology.

[31]  I. Palacios,et al.  Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy. , 1987, Circulation.

[32]  J. Mehlsen,et al.  Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. , 1999, Diabetes care.

[33]  Wolfgang A Linke,et al.  Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.

[34]  Yiming Wu,et al.  Nebulin regulates thin filament length, contractility, and Z‐disk structure in vivo , 2006, The EMBO journal.

[35]  M. Roberts,et al.  Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.

[36]  Romuald Wojnicz,et al.  Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results , 2001, Circulation.

[37]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[38]  S. Yusuf,et al.  Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk , 2007, Circulation.

[39]  F. Villarreal,et al.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[40]  D. Kass,et al.  Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. , 1996, Circulation.

[41]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[42]  G. Lopaschuk.  Metabolic Abnormalities in the Diabetic Heart , 2002, Heart Failure Reviews.

[43]  C. Visser,et al.  Nϵ-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[44]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[45]  H. Schultheiss,et al.  Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence, Endothelial Activation, and Myocardial Leukocyte Infiltrates , 2005, Circulation.

[46]  G. Heyndrickx,et al.  Wide-range load shift of combined aortic valvuloplasty-arterial vasodilation slows isovolumic relaxation of the hypertrophied left ventricle. , 1990, Circulation.

[47]  Istvan Edes,et al.  Cardiomyocyte Stiffness in Diastolic Heart Failure , 2005, Circulation.

[48]  Masahiko Hoshijima,et al.  Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. , 2006, American journal of physiology. Heart and circulatory physiology.

[49]  D. Kass,et al.  Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension , 2007, Journal of hypertension.

[50]  I. Poornima,et al.  Diabetic cardiomyopathy: the search for a unifying hypothesis. , 2006, Circulation research.

[51]  D. Kass,et al.  Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota , 2007, Circulation.

[52]  L. Sleeper,et al.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. , 2004, Journal of the American College of Cardiology.

[53]  S. Solomon,et al.  Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial , 2007, The Lancet.